General Information of DTT (ID: TT2GIDQ)

DTT Name C-C chemokine receptor type 7 (CCR7) DTT Info
Gene Name CCR7

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
JBH492 DM7XAV1 Chronic lymphocytic leukaemia 2A82.0 Phase 1 [1]
CAP-100 DM1CVX3 Chronic lymphocytic leukaemia 2A82.0 Clinical trial [2]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 ClinicalTrials.gov (NCT04240704) Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL). U.S. National Institutes of Health.
2 Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody. Cancer Immunol Immunother. 2022 Mar;71(3):627-636.